BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ordoñez R, Carbajo-Pescador S, Prieto-Dominguez N, García-Palomo A, González-Gallego J, Mauriz JL. Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells. J Pineal Res 2014;56:20-30. [PMID: 24117795 DOI: 10.1111/jpi.12092] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Li W, Wang Z, Chen Y, Wang K, Lu T, Ying F, Fan M, Li Z, Wu J. Melatonin treatment induces apoptosis through regulating the nuclear factor-κB and mitogen-activated protein kinase signaling pathways in human gastric cancer SGC7901 cells. Oncol Lett 2017;13:2737-44. [PMID: 28454460 DOI: 10.3892/ol.2017.5785] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
2 Hsieh SC, Tsai JP, Yang SF, Tang MJ, Hsieh YH. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression. Amino Acids 2014;46:2809-22. [PMID: 25245054 DOI: 10.1007/s00726-014-1838-4] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
3 Tang H, Shi X, Zhu P, Guo W, Li J, Yan B, Zhang S. Melatonin inhibits gallbladder cancer cell migration and invasion via ERK-mediated induction of epithelial-to-mesenchymal transition. Oncol Lett 2021;22:609. [PMID: 34188711 DOI: 10.3892/ol.2021.12870] [Reference Citation Analysis]
4 Li Y, Li S, Zhou Y, Meng X, Zhang JJ, Xu DP, Li HB. Melatonin for the prevention and treatment of cancer.Oncotarget. 2017;8:39896-39921. [PMID: 28415828 DOI: 10.18632/oncotarget.16379] [Cited by in Crossref: 137] [Cited by in F6Publishing: 125] [Article Influence: 34.3] [Reference Citation Analysis]
5 Gill MB, Zeng F, Shabala L, Zhang G, Yu M, Demidchik V, Shabala S, Zhou M. Identification of QTL Related to ROS Formation under Hypoxia and Their Association with Waterlogging and Salt Tolerance in Barley. Int J Mol Sci 2019;20:E699. [PMID: 30736310 DOI: 10.3390/ijms20030699] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
6 Sun MJ, Cao ZQ, Leng P. The roles of galectins in hepatic diseases. J Mol Histol 2020;51:473-84. [PMID: 32734557 DOI: 10.1007/s10735-020-09898-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Zhang JJ, Meng X, Li Y, Zhou Y, Xu DP, Li S, Li HB. Effects of Melatonin on Liver Injuries and Diseases. Int J Mol Sci 2017;18:E673. [PMID: 28333073 DOI: 10.3390/ijms18040673] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
8 Yi C, Zhang Y, Yu Z, Xiao Y, Wang J, Qiu H, Yu W, Tang R, Yuan Y, Guo W, Deng W. Melatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2/iNOS and NF-κB/p300 signaling pathways. PLoS One 2014;9:e99943. [PMID: 25000190 DOI: 10.1371/journal.pone.0099943] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
9 Wang Q, Sun Z, Du L, Xu C, Wang Y, Yang B, He N, Wang J, Ji K, Liu Y, Liu Q. Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo. Int J Mol Sci 2018;19:E3974. [PMID: 30544713 DOI: 10.3390/ijms19123974] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
10 Kittiwattanokhun A, Samosorn S, Innajak S, Watanapokasin R. Inhibitory effects on chondrosarcoma cell metastasis by Senna alata extract. Biomed Pharmacother 2021;137:111337. [PMID: 33582453 DOI: 10.1016/j.biopha.2021.111337] [Reference Citation Analysis]
11 Xin Z, Jiang S, Jiang P, Yan X, Fan C, Di S, Wu G, Yang Y, Reiter RJ, Ji G. Melatonin as a treatment for gastrointestinal cancer: a review. J Pineal Res. 2015;58:375-387. [PMID: 25752643 DOI: 10.1111/jpi.12227] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 8.9] [Reference Citation Analysis]
12 Maleki Dana P, Reiter RJ, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B. Melatonin as a potential inhibitor of kidney cancer: A survey of the molecular processes. IUBMB Life 2020;72:2355-65. [PMID: 32918860 DOI: 10.1002/iub.2384] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang X, An X, Wang X, Hu X, Bi J, Tong L, Yang D, Song Y, Bai C. Peroxiredoxin 6 knockout aggravates cecal ligation and puncture-induced acute lung injury. Int Immunopharmacol 2019;68:252-8. [PMID: 30683539 DOI: 10.1016/j.intimp.2018.12.053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
14 Shrestha S, Zhu J, Wang Q, Du X, Liu F, Jiang J, Song J, Xing J, Sun D, Hou Q, Peng Y, Zhao J, Sun X, Song X. Melatonin potentiates the antitumor effect of curcumin by inhibiting IKKβ/NF-κB/COX-2 signaling pathway. Int J Oncol 2017;51:1249-60. [PMID: 28849163 DOI: 10.3892/ijo.2017.4097] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
15 Fernández-Palanca P, Méndez-Blanco C, Fondevila F, Tuñón MJ, Reiter RJ, Mauriz JL, González-Gallego J. Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review. Antioxidants (Basel) 2021;10:103. [PMID: 33445767 DOI: 10.3390/antiox10010103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
16 Verma S, Kesh K, Ganguly N, Jana S, Swarnakar S. Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants. World J Biol Chem 2014; 5(3): 355-376 [PMID: 25225603 DOI: 10.4331/wjbc.v5.i3.355] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
17 Lin JJ, Su JH, Tsai CC, Chen YJ, Liao MH, Wu YJ. 11-epi-Sinulariolide acetate reduces cell migration and invasion of human hepatocellular carcinoma by reducing the activation of ERK1/2, p38MAPK and FAK/PI3K/AKT/mTOR signaling pathways. Mar Drugs 2014;12:4783-98. [PMID: 25222667 DOI: 10.3390/md12094783] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
18 Lee JI, Kil J, Yu GH, Karadeniz F, Oh JH, Seo Y, Kong C. 3,5-Dicaffeoyl-epi-quinic acid inhibits the PMA-stimulated activation and expression of MMP-9 but not MMP-2 via downregulation of MAPK pathway. Zeitschrift für Naturforschung C 2020;75:113-20. [DOI: 10.1515/znc-2019-0163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Custódio PR, Colombo J, Ventura FV, Castro TB, Zuccari DAPC. Melatonin Treatment Combined with TGF-β Silencing Inhibits Epithelial- Mesenchymal Transition in CF41 Canine Mammary Cancer Cell Line. Anticancer Agents Med Chem 2020;20:989-97. [PMID: 32264814 DOI: 10.2174/1871520620666200407122635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Prieto-Domínguez N, Méndez-Blanco C, Carbajo-Pescador S, Fondevila F, García-Palomo A, González-Gallego J, Mauriz JL. Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy. Oncotarget 2017;8:91402-14. [PMID: 29207653 DOI: 10.18632/oncotarget.20592] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
21 Ma Z, Yang Y, Fan C, Han J, Wang D, Di S, Hu W, Liu D, Li X, Reiter RJ, Yan X. Melatonin as a potential anticarcinogen for non-small-cell lung cancer. Oncotarget 2016;7:46768-84. [PMID: 27102150 DOI: 10.18632/oncotarget.8776] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 15.3] [Reference Citation Analysis]
22 Ramamoorthy H, Abraham P, Isaac B, Selvakumar D. Role for NF-κB inflammatory signalling pathway in tenofovir disoproxil fumarate (TDF) induced renal damage in rats. Food and Chemical Toxicology 2017;99:103-18. [DOI: 10.1016/j.fct.2016.11.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
23 Kubatka P, Zubor P, Busselberg D, Kwon TK, Adamek M, Petrovic D, Opatrilova R, Gazdikova K, Caprnda M, Rodrigo L, Danko J, Kruzliak P. Melatonin and breast cancer: Evidences from preclinical and human studies. Critical Reviews in Oncology/Hematology 2018;122:133-43. [DOI: 10.1016/j.critrevonc.2017.12.018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 10.0] [Reference Citation Analysis]
24 Tuli HS, Kashyap D, Sharma AK, Sandhu SS. Molecular aspects of melatonin (MLT)-mediated therapeutic effects. Life Sciences 2015;135:147-57. [DOI: 10.1016/j.lfs.2015.06.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
25 Elewa MA, Al-Gayyar MM, Schaalan MF, Abd El Galil KH, Ebrahim MA, El-Shishtawy MM. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers. Clin Exp Metastasis 2015;32:479-93. [PMID: 25999065 DOI: 10.1007/s10585-015-9721-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
26 Sánchez DI, González-Fernández B, San-Miguel B, de Urbina JO, Crespo I, González-Gallego J, Tuñón MJ. Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma. J Pineal Res 2017;62. [PMID: 27696512 DOI: 10.1111/jpi.12369] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
27 Talib WH. Melatonin and Cancer Hallmarks. Molecules 2018;23:E518. [PMID: 29495398 DOI: 10.3390/molecules23030518] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 13.0] [Reference Citation Analysis]
28 Li Y, Zhou T, Cheng X, Li D, Zhao M, Zheng WV. microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3. Bioengineered 2022;13:4730-43. [DOI: 10.1080/21655979.2022.2031408] [Reference Citation Analysis]
29 González-Fernández B, Sánchez DI, González-Gallego J, Tuñón MJ. Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy. Front Pharmacol 2017;8:579. [PMID: 28890699 DOI: 10.3389/fphar.2017.00579] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
30 González-González A, González A, Rueda N, Alonso-González C, Menéndez-Menéndez J, Gómez-Arozamena J, Martínez-Campa C, Cos S. Melatonin Enhances the Usefulness of Ionizing Radiation: Involving the Regulation of Different Steps of the Angiogenic Process. Front Physiol 2019;10:879. [PMID: 31354524 DOI: 10.3389/fphys.2019.00879] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
31 Plaimee P, Khamphio M, Weerapreeyakul N, Barusrux S, Johns NP. Immunomodulatory effect of melatonin in SK-LU-1 human lung adenocarcinoma cells co-cultured with peripheral blood mononuclear cells. Cell Prolif 2014;47:406-15. [PMID: 25053373 DOI: 10.1111/cpr.12119] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
32 Fatemi I, Dehdashtian E, Pourhanifeh MH, Mehrzadi S, Hosseinzadeh A. Therapeutic Application of Melatonin in the Treatment of Melanoma: A Review. CCTR 2021;17:283-91. [DOI: 10.2174/1573394717666210526140950] [Reference Citation Analysis]
33 Tomasi ML, Ramani K. SUMOylation and phosphorylation cross-talk in hepatocellular carcinoma. Transl Gastroenterol Hepatol 2018;3:20. [PMID: 29780898 DOI: 10.21037/tgh.2018.04.04] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
34 Ammar OA, El-missiry MA, Othman AI, Amer ME. Melatonin is a potential oncostatic agent to inhibit HepG2 cell proliferation through multiple pathways. Heliyon 2022;8:e08837. [DOI: 10.1016/j.heliyon.2022.e08837] [Reference Citation Analysis]
35 Ordoñez R, Fernández A, Prieto-Domínguez N, Martínez L, García-Ruiz C, Fernández-Checa JC, Mauriz JL, González-Gallego J. Ceramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells. J Pineal Res 2015;59:178-89. [PMID: 25975536 DOI: 10.1111/jpi.12249] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 8.6] [Reference Citation Analysis]
36 Pourhanifeh MH, Mehrzadi S, Kamali M, Hosseinzadeh A. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways. Eur J Pharmacol 2020;886:173471. [PMID: 32877658 DOI: 10.1016/j.ejphar.2020.173471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
37 Ding K, Wang H, Xu J, Li T, Zhang L, Ding Y, Zhu L, He J, Zhou M. Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism. Free Radic Biol Med 2014;73:1-11. [PMID: 24810171 DOI: 10.1016/j.freeradbiomed.2014.04.031] [Cited by in Crossref: 129] [Cited by in F6Publishing: 124] [Article Influence: 16.1] [Reference Citation Analysis]
38 El-Magd MA, Mohamed Y, El-Shetry ES, Elsayed SA, Abo Gazia M, Abdel-Aleem GA, Shafik NM, Abdo WS, El-Desouki NI, Basyony MA. Melatonin maximizes the therapeutic potential of non-preconditioned MSCs in a DEN-induced rat model of HCC. Biomed Pharmacother 2019;114:108732. [PMID: 30925457 DOI: 10.1016/j.biopha.2019.108732] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
39 Mortazavi SAR, Mortazavi SMJ. Women with hereditary breast cancer predispositions should avoid using their smartphones, tablets, and laptops at night. Iran J Basic Med Sci 2018;21:112-5. [PMID: 29456806 DOI: 10.22038/IJBMS.2018.27711.6751] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
40 Colombo J, Maciel JM, Ferreira LC, DA Silva RF, Zuccari DA. Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells. Oncol Lett. 2016;12:231-237. [PMID: 27347130 DOI: 10.3892/ol.2016.4605] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
41 Moreira AJ, Ordoñez R, Cerski CT, Picada JN, García-Palomo A, Marroni NP, Mauriz JL, González-Gallego J. Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis. PLoS One 2015;10:e0144517. [PMID: 26656265 DOI: 10.1371/journal.pone.0144517] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
42 Shajari S, Laliena A, Heegsma J, Tuñón MJ, Moshage H, Faber KN. Melatonin suppresses activation of hepatic stellate cells through RORα-mediated inhibition of 5-lipoxygenase. J Pineal Res 2015;59:391-401. [PMID: 26308880 DOI: 10.1111/jpi.12271] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
43 Yeh CM, Lin CW, Yang JS, Yang WE, Su SC, Yang SF. Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation. Oncotarget 2016;7:21952-67. [PMID: 26980735 DOI: 10.18632/oncotarget.8009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
44 Liu S, Liang B, Jia H, Jiao Y, Pang Z, Huang Y. Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells. FEBS Open Bio 2017;7:798-810. [PMID: 28593135 DOI: 10.1002/2211-5463.12223] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
45 Sivandzade F, Prasad S, Bhalerao A, Cucullo L. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches. Redox Biol 2019;21:101059. [PMID: 30576920 DOI: 10.1016/j.redox.2018.11.017] [Cited by in Crossref: 149] [Cited by in F6Publishing: 148] [Article Influence: 37.3] [Reference Citation Analysis]
46 Mortezaee K. Human hepatocellular carcinoma: Protection by melatonin. J Cell Physiol 2018;233:6486-508. [DOI: 10.1002/jcp.26586] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
47 Lin YW, Lee LM, Lee WJ, Chu CY, Tan P, Yang YC, Chen WY, Yang SF, Hsiao M, Chien MH. Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity. J Pineal Res 2016;60:277-90. [PMID: 26732239 DOI: 10.1111/jpi.12308] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 16.2] [Reference Citation Analysis]
48 Plaimee P, Weerapreeyakul N, Barusrux S, Johns NP. Melatonin potentiates cisplatin-induced apoptosis and cell cycle arrest in human lung adenocarcinoma cells. Cell Prolif 2015;48:67-77. [PMID: 25580987 DOI: 10.1111/cpr.12158] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 7.7] [Reference Citation Analysis]
49 Goradel NH, Asghari MH, Moloudizargari M, Negahdari B, Haghi-aminjan H, Abdollahi M. Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence. Toxicology and Applied Pharmacology 2017;335:56-63. [DOI: 10.1016/j.taap.2017.09.022] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
50 Talib WH, Alsayed AR, Abuawad A, Daoud S, Mahmod AI. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities. Molecules 2021;26:2506. [PMID: 33923028 DOI: 10.3390/molecules26092506] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
51 Sun B, Yang S, Li S, Hang C. Melatonin Upregulates Nuclear Factor Erythroid-2 Related Factor 2 (Nrf2) and Mediates Mitophagy to Protect Against Early Brain Injury After Subarachnoid Hemorrhage. Med Sci Monit 2018;24:6422-30. [PMID: 30210141 DOI: 10.12659/MSM.909221] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
52 Shen H, Yu H, Li QY, Wei YT, Fu J, Dong H, Cao D, Guo LN, Chen L, Yang Y, Xu Y, Wu MC, Wang HY, Chen Y. Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells. Acta Pharmacol Sin 2022. [PMID: 35508720 DOI: 10.1038/s41401-022-00907-5] [Reference Citation Analysis]
53 Li XP, Cui DL. Role of tumor microenvironment in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2014; 22(9): 1219-1225 [DOI: 10.11569/wcjd.v22.i9.1219] [Reference Citation Analysis]
54 Sánchez DI, González-Fernández B, Crespo I, San-Miguel B, Álvarez M, González-Gallego J, Tuñón MJ. Melatonin modulates dysregulated circadian clocks in mice with diethylnitrosamine-induced hepatocellular carcinoma. J Pineal Res 2018;65:e12506. [PMID: 29770483 DOI: 10.1111/jpi.12506] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
55 Moreno ACR, Porchia BFMM, Pagni RL, Souza PDC, Pegoraro R, Rodrigues KB, Barros TB, Aps LRMM, de Araújo EF, Calich VLG, Ferreira LCS. The Combined Use of Melatonin and an Indoleamine 2,3-Dioxygenase-1 Inhibitor Enhances Vaccine-Induced Protective Cellular Immunity to HPV16-Associated Tumors. Front Immunol 2018;9:1914. [PMID: 30186285 DOI: 10.3389/fimmu.2018.01914] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
56 Avcı E, Arıkoğlu H, Erkoç Kaya D. Investigation of juglone effects on metastasis and angiogenesis in pancreatic cancer cells. Gene 2016;588:74-8. [DOI: 10.1016/j.gene.2016.05.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
57 Shohrati M, Haji Hosseini R, Esfandiari MA, Najafian N, Najafian B, Golbedagh A. Serum matrix metalloproteinase levels in patients exposed to sulfur mustard. Iran Red Crescent Med J 2014;16:e15129. [PMID: 24829780 DOI: 10.5812/ircmj.15129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
58 Chen K, Zhu P, Chen W, Luo K, Shi XJ, Zhai W. Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells. Aging (Albany NY) 2021;13:22502-15. [PMID: 34580235 DOI: 10.18632/aging.203561] [Reference Citation Analysis]
59 Mirza-Aghazadeh-Attari M, Reiter RJ, Rikhtegar R, Jalili J, Hajalioghli P, Mihanfar A, Majidinia M, Yousefi B. Melatonin: An atypical hormone with major functions in the regulation of angiogenesis. IUBMB Life 2020;72:1560-84. [PMID: 32329956 DOI: 10.1002/iub.2287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
60 Meng X, Li Y, Li S, Zhou Y, Gan RY, Xu DP, Li HB. Dietary Sources and Bioactivities of Melatonin. Nutrients. 2017;9:367. [PMID: 28387721 DOI: 10.3390/nu9040367] [Cited by in Crossref: 99] [Cited by in F6Publishing: 87] [Article Influence: 19.8] [Reference Citation Analysis]
61 Prieto-Domínguez N, Ordóñez R, Fernández A, Méndez-Blanco C, Baulies A, Garcia-Ruiz C, Fernández-Checa JC, Mauriz JL, González-Gallego J. Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy. J Pineal Res 2016;61:396-407. [PMID: 27484637 DOI: 10.1111/jpi.12358] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 13.3] [Reference Citation Analysis]
62 Ostrycharz E, Wasik U, Kempinska-Podhorodecka A, Banales JM, Milkiewicz P, Milkiewicz M. Melatonin Protects Cholangiocytes from Oxidative Stress-Induced Proapoptotic and Proinflammatory Stimuli via miR-132 and miR-34. Int J Mol Sci 2020;21:E9667. [PMID: 33352965 DOI: 10.3390/ijms21249667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 El-Din MS, Taha AM, Sayed AA, Salem AM. Ziziphus spina-christi leaves methanolic extract alleviates diethylnitrosamine-induced hepatocellular carcinoma in rats. Biochem Cell Biol 2019;97:437-45. [PMID: 30605366 DOI: 10.1139/bcb-2018-0318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
64 Gelaleti GB, Borin TF, Maschio-Signorini LB, Moschetta MG, Jardim-Perassi BV, Calvinho GB, Facchini MC, Viloria-Petit AM, de Campos Zuccari DAP. Efficacy of melatonin, IL-25 and siIL-17B in tumorigenesis-associated properties of breast cancer cell lines. Life Sci 2017;183:98-109. [PMID: 28624391 DOI: 10.1016/j.lfs.2017.06.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
65 Gonçalves Ndo N, Colombo J, Lopes JR, Gelaleti GB, Moschetta MG, Sonehara NM, Hellmén E, Zanon Cde F, Oliani SM, Zuccari DA. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines. PLoS One 2016;11:e0150407. [PMID: 26934679 DOI: 10.1371/journal.pone.0150407] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
66 Angelopoulou E, Piperi C, Adamopoulos C, Papavassiliou AG. Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression. J Mol Med 2016;94:867-74. [DOI: 10.1007/s00109-016-1435-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
67 Lu KH, Su SC, Lin CW, Hsieh YH, Lin YC, Chien MH, Reiter RJ, Yang SF. Melatonin attenuates osteosarcoma cell invasion by suppression of C-C motif chemokine ligand 24 through inhibition of the c-Jun N-terminal kinase pathway. J Pineal Res 2018;65:e12507. [PMID: 29766567 DOI: 10.1111/jpi.12507] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
68 Kong L, Li S, Huang M, Xiong Y, Zhang Q, Ye L, Liu J, Zhu X, Sun R, Guo Y. The roles of endoplasmic reticulum overload response induced by HCV and NS4B protein in human hepatocyte viability and virus replication. PLoS One 2015;10:e0123190. [PMID: 25875501 DOI: 10.1371/journal.pone.0123190] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
69 Wiggins-dohlvik K, Han MS, Stagg HW, Alluri H, Shaji CA, Oakley RP, Davis ML, Tharakan B. Melatonin inhibits thermal injury–induced hyperpermeability in microvascular endothelial cells. Journal of Trauma and Acute Care Surgery 2014;77:899-905. [DOI: 10.1097/ta.0000000000000346] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
70 Cheng TC, Din ZH, Su JH, Wu YJ, Liu CI. Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells. Mar Drugs 2017;15:E238. [PMID: 28767067 DOI: 10.3390/md15080238] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
71 Liu Z, Zou D, Yang X, Xue X, Zuo L, Zhou Q, Hu R, Wang Y. Melatonin inhibits colon cancer RKO cell migration by downregulating Rho‑associated protein kinase expression via the p38/MAPK signaling pathway. Mol Med Rep 2017;16:9383-92. [PMID: 29152648 DOI: 10.3892/mmr.2017.7836] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
72 Liu J, Sha M, Wang Q, Ma Y, Geng X, Gao Y, Feng L, Shen Y, Shen Y. Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma. BMC Cancer 2015;15:675. [PMID: 26458400 DOI: 10.1186/s12885-015-1665-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
73 Ho H, Lin C, Chien M, Reiter RJ, Su S, Hsieh Y, Yang S. Melatonin suppresses TPA-induced metastasis by downregulating matrix metalloproteinase-9 expression through JNK/SP-1 signaling in nasopharyngeal carcinoma. J Pineal Res 2016;61:479-92. [DOI: 10.1111/jpi.12365] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 11.0] [Reference Citation Analysis]
74 Ju HQ, Li H, Tian T, Lu YX, Bai L, Chen LZ, Sheng H, Mo HY, Zeng JB, Deng W, Chiao PJ, Xu RH. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation. J Pineal Res 2016;60:27-38. [PMID: 26445000 DOI: 10.1111/jpi.12285] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]